Understanding the Perseverance of the Muscular Dystrophy Community One-Year into the COVID-19 Pandemic
Author(s) -
Leann Lewis,
Katy Eichinger,
Nuran Dilek,
Kiley Higgs,
Michaela Walker,
David Palmer,
John M. Cooley,
Nicholas J. Johnson,
Rabi Tawil,
Jeffrey Statland
Publication year - 2022
Publication title -
journal of neuromuscular diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.366
H-Index - 23
eISSN - 2214-3602
pISSN - 2214-3599
DOI - 10.3233/jnd-220794
Subject(s) - medicine , facioscapulohumeral muscular dystrophy , muscular dystrophy , pandemic , dysferlin , disease , telemedicine , physical therapy , telehealth , covid-19 , myotonic dystrophy , health care , pediatrics , gerontology , infectious disease (medical specialty) , economics , economic growth
In this study, we examined the long-term social and health impacts of the coronavirus disease 2019 (COVID-19) pandemic on people with muscular dystrophy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom